Label: INTOMEDI FIRST AMPOULE PEPTIDE- sodium hyaluronate liquid
- NDC Code(s): 82879-0006-1, 82879-0006-2
- Packager: Janytree Inc.
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
- Marketing Status: unapproved drug other
DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
Drug Label Information
Updated July 12, 2022
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
-
INACTIVE INGREDIENTS
Water, Ethyl Ascorbyl Ether, Dipropylene Glycol, Butylene Glycol, Glycerin, 1,2-Hexanediol, Lactobacillus
/Hydrolyzed Pea Seed Extract Ferment Filtrate(Bio-Peptone®), Dimethyl Sulfone, Snail Secretion Filtrate,
Panthenol, Centella Asiatica Extract, Pentylene Glycol, Ethyl Hexanediol, Mentha Piperita (Peppermint)
Extract, Phenoxyethanol, Hydrolyzed Collagen, Allantoin, Polygonum Cuspidatum
Root Extract, Scutellaria Baicalensis Root Extract, Camellia Sinensis Leaf Extract, Glycyrrhiza Glabra
(Licorice) Root Extract, Sodium Hyaluronate Crosspolymer, Rosmarinus Officinalis (Rosemary) Leaf
Extract, Chamomilla Recutita (Matricaria) Flower Extract, Nicotinoyl Hexapeptide-44, Caffeoyl
sh-Decapeptide-9, sh-Oligopeptide-1(EGF), sh-Oligopeptide-2(IGF), sh-Polypeptide-64(AQP) - ACTIVE INGREDIENTS
- PURPOSE
-
WARNINGS
For external use only When using this product
■ If following abnormal symptoms occurs after using the product, stop using the product and consult with a skin specialist. Symptoms : Red specks, swelling, itching
■ Do not use on the skin parts affected by wound, eczema, or dermatitis.
Keep out of reach of children.
■ If swallowed, get a medical help or contact a person in control center immediately.
■ Avoid contact with eyes. - KEEP OUT OF REACH OF CHILDREN
- INDICATIONS & USAGE
- DOSAGE & ADMINISTRATION
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
INTOMEDI FIRST AMPOULE PEPTIDE
sodium hyaluronate liquidProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:82879-0006 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength HYALURONATE SODIUM (UNII: YSE9PPT4TH) (HYALURONIC ACID - UNII:S270N0TRQY) HYALURONATE SODIUM 0.5 g in 100 mL Inactive Ingredients Ingredient Name Strength BUTYLENE GLYCOL (UNII: 3XUS85K0RA) WATER (UNII: 059QF0KO0R) GLYCERIN (UNII: PDC6A3C0OX) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:82879-0006-2 5 in 1 PACKAGE 07/13/2022 1 NDC:82879-0006-1 5 mL in 1 BOTTLE; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 07/13/2022 Labeler - Janytree Inc. (688403840) Registrant - Janytree Inc. (688403840) Establishment Name Address ID/FEI Business Operations Janytree Inc. 688403840 manufacture(82879-0006)
